PharmaShots | Incisive News in 3 Shots

Subscribe Now

treated

BMS' Revlimid + Rituximab Receives EC's Approval to Treat Adults Previously Treated Follicular Lymphoma (Grade 1-3a)

BMS' Revlimid + Rituximab Receives EC's Approval to Treat Adults Previously Treated Follicular Lymphoma (Grade 1-3a)

December 23, 2019

BMS Reports Acceptance of sBLA for Opdivo (nivolumab) + Yervoy (ipilimumab) for Patients with Previously Treated Advanced Hepatocellular Carcinoma

BMS Reports Acceptance of sBLA for Opdivo (nivolumab) + Yervoy (ipilimumab) for Patients with Previously Treated Advanced Hepatoce...

November 12, 2019

AstraZeneca Canada's Calquence (acalabrutinib) Receives Health Canada Approval for Patients Previously Treated with Mantle Cell Lymphoma (MCL)

AstraZeneca Canada's Calquence (acalabrutinib) Receives Health Canada Approval for Patients Previously Treated with Mantle Cell Ly...

October 9, 2019

Incyte Reports Updated Results of Pemigatinib in P-II FIGHT-202 Trial for Patients with Previously Treated Advanced Cholangiocarcinoma

Incyte Reports Updated Results of Pemigatinib in P-II FIGHT-202 Trial for Patients with Previously Treated Advanced Cholangiocarci...

September 27, 2019

Exelixis' Cabometyx (cabozantinib) Receives FDA Approval for Previously Treated Hepatocellular Carcinoma (HCC)

Exelixis' Cabometyx (cabozantinib) Receives FDA Approval for Previously Treated Hepatocellular Carcinoma (HCC)

January 15, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us